HAE Haemonetics Corporation Common Stock
$107,27
Preço · Ago 21, 2026
Fundamentais a partir de Ago 6, 2026
Intervalo 52 Semanas
$47–$110
96% of range
Classificação do Analista
BUY
15 analysts
Preço-Alvo
$104
P/E (TTM)
52.3
ROE
11.8%
Margem de Lucro Líquido
7.3%
Sobre Haemonetics Corporation Common Stock Visão geral da empresa da Wikipedia
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Ler mais
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
History
The company was founded in 1971. Haemonetics started out producing the containers and bags required for blood collection. The Latham Bowl was a disposable container that could automate the separation of blood by centrifugation. Through the 90's, the company added additional product lines and technologies. The company opened a manufacturing facility in Holbrook, Massachusetts in 1988.
In 1995 the company purchased the Intravenous Solutions manufacturing facility in Union, South Carolina.
Additional acquisitions grew the company and expanded its services. In the following years the company branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. These acquisitions included Edmonton-based Fifth Dimension (5D) Information Systems to gain entry into the blood and plasma software industry. Further acquisitions include Chicago-based Arryx in July 2006, Information Data Management, Inc. in January 2007, the acquisition of a division of Haemoscope in 2007, the acquisition of Infonale in July 2007, and, in 2009, Chico, California-based Altivation and Tucson, Arizona-based Sebra.
On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions. The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.
Further acquisitions included the April 2009 acquisition of Neoteric Technology Ltd and the April 2010 acquisition of California-based Global Med Technologies, Inc. Haemonetics acquired the Pall Corporation's transfusion medicine business on August 1, 2012 for ~$550 million.
In April 2024, it was announced Haemonetics had completed its acquisition of the Chicago-headquartered medical device temperature regulation manufacturer, Attune Medical for $160 million.
Product categories
Haemonetics products can be considered as belonging to two broad categories. Donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit); and products that are marketed to the surgical suite for blood loss management for patients. These products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.
Hemostasis
TEG 5000
Kaolin TEG
Kaolin TEG with Heparinase
RapidTEG
TEG Functional Fibrinogen
TEG PlateletMapping
TEG 6S
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
HAE Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$107.27
Capitalização de Mercado
$4.85B
P/E (TTM)
52.3
EPS (TTM)
$2.05
Receita (TTM)
$1.33B
Rendimento div.
—
ROE
11.8%
Dívida/Capital
1.5
Intervalo 52 Semanas
$47 – $110
HAE Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$1.33B
2017-04-01
→
2026-03-28
EPS
$2.05
2017-04-01
→
2026-03-28
Fluxo de caixa livre
$260M
2017-04-01
→
2026-03-28
Margens
7.3%
2017-04-01
→
2026-03-28
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
HAE
Mediana de Pares
P/E (TTM)
52.3
39.4
P/S (TTM)
3.6
2.1
P/B
6.1
3.3
EV / EBITDA
37.2
—
Price / FCF (Preço / FCF)
18.6
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
HAE
Mediana de Pares
Gross Margin (Margem Bruta)
59.0%
58.7%
Operating Margin (Margem Operacional)
11.8%
—
Net Profit Margin (Margem de Lucro Líquido)
7.3%
-11.8%
ROA
4.0%
-6.3%
ROE
11.8%
-13.4%
ROIC
5.9%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
HAE
Mediana de Pares
Debt / Equity (Dívida / Patrimônio Líquido)
1.5
37.4
Current Ratio (Índice de liquidez corrente)
3.0
2.4
Quick Ratio (Índice de Liquidez Seca)
1.6
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
HAE
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-2.0%
—
Revenue CAGR 3Y (CAGR Receita 3A)
4.5%
—
Revenue CAGR 5Y (CAGR Receita 5A)
8.9%
—
EPS YoY
-38.1%
—
Net Income YoY (Lucro Líquido Ano a Ano)
-42.0%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
HAE
Mediana de Pares
HAE Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
15 analistas
- Compra forte 5 33,3%
- Compra 6 40,0%
- Manter 4 26,7%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
10 analistas · 2026-08-20
Mediana
$104.50
Agora
$107.27
Mín
$86.00
Máx
$120.00
Alvo mediano
$104.50
-2,6%
Alvo médio
$104.10
-3,0%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.06%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2027 | $1.14 | $1.09 | 0.05% |
| 30 de Junho de 2026 | $1.14 | $1.09 | 0.05% |
| 31 de Março de 2026 | $1.29 | $1.28 | 0.01% |
| 31 de Dezembro de 2025 | $1.31 | $1.26 | 0.05% |
| 30 de Setembro de 2025 | $1.27 | $1.12 | 0.15% |
| 30 de Junho de 2025 | $1.10 | $1.03 | 0.07% |
| 31 de Março de 2025 | $1.24 | $1.23 | 0.01% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 16
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Cost of Revenue | $546M | $612M | $618M | $554M | $488M | $473M | $504M | $550M | $492M | $508M | $503M | $476M | |
| Gross Profit | $788M | $749M | $692M | $615M | $506M | $398M | $485M | $418M | $412M | $378M | $406M | $434M | |
| R&D Expense | $60M | $63M | $54M | $50M | $47M | $33M | $31M | $36M | $39M | $38M | $45M | $54M | |
| SG&A Expense | $442M | $437M | $430M | $377M | $340M | $275M | $282M | $273M | $317M | $302M | $317M | $337M | |
| Operating Expenses | $631M | $527M | $527M | $459M | $425M | $308M | $381M | $334M | $356M | $398M | $450M | $394M | |
| Operating Income | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M | |
| Other Non-op | $-29M | $-10M | $-13M | $-15M | $-17M | $-17M | $-16M | $-10M | $-5M | $-8M | $-9M | $-9M | |
| Pretax Income | $128M | $212M | $152M | $141M | $64M | $73M | $87M | $74M | $60M | $-27M | $-53M | $31M | |
| Income Tax | $31M | $44M | $34M | $26M | $20M | $-7M | $11M | $19M | $14M | $-1M | $2M | $14M | |
| Net Income | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| EPS (Basic) | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | $-0.51 | $-1.09 | $0.33 | |
| EPS (Diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 | $-1.09 | $0.32 | |
| Shares (Basic) | 47,179,000 | 50,330,000 | 50,706,000 | 50,783,000 | 51,047,000 | 50,688,000 | 50,692,000 | 51,533,000 | 52,755,000 | 51,524,000 | 50,910,000 | 51,533,000 | |
| Shares (Diluted) | 47,354,000 | 50,730,000 | 51,397,000 | 51,420,000 | 51,353,000 | 51,292,000 | 51,815,000 | 52,942,000 | 53,501,000 | 51,524,000 | 50,910,000 | 52,089,000 | |
| EBITDA | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M |
Balanço Patrimonial 25
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $245M | $307M | $179M | $284M | $259M | $192M | $137M | $169M | $180M | $140M | $115M | $161M | |
| Receivables | $217M | $203M | $207M | $179M | $159M | $128M | $165M | $185M | $151M | $153M | $157M | $146M | |
| Inventory | $306M | $365M | $317M | $259M | $293M | $323M | $270M | $194M | $161M | $177M | $187M | $211M | |
| Prepaid Expense | $66M | $60M | $66M | $47M | $44M | $51M | $31M | $27M | $29M | $41M | $29M | $40M | |
| Current Assets | $835M | $935M | $769M | $770M | $756M | $694M | $604M | $576M | $521M | $510M | $488M | $558M | |
| PP&E (Net) | $306M | $284M | $311M | $311M | $258M | $218M | $253M | $344M | $332M | $324M | $338M | $322M | |
| PP&E (Gross) | $842M | $837M | $959M | $944M | $869M | $817M | $832M | $933M | $873M | $807M | $786M | $732M | |
| Accum. Depreciation | $536M | $553M | $648M | $633M | $611M | $600M | $579M | $589M | $541M | $484M | $449M | $410M | |
| Goodwill | $656M | $604M | $565M | $466M | $467M | $466M | $211M | $211M | $211M | $211M | $268M | $334M | |
| Intangibles | $448M | $456M | $406M | $276M | $310M | $365M | $133M | $128M | $157M | $178M | $204M | $245M | |
| Other Non-current Assets | $142M | $164M | $136M | $107M | $63M | $71M | $62M | $12M | $12M | $12M | $14M | $11M | |
| Total Assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Accounts Payable | $51M | $67M | $73M | $64M | $58M | $50M | $51M | $63M | $55M | $43M | $40M | $48M | |
| Current Liabilities | $283M | $578M | $300M | $252M | $442M | $253M | $275M | $236M | $385M | $211M | $186M | $189M | |
| Capital Leases | $41M | $50M | $58M | $56M | $56M | $63M | $52M | · | · | · | · | · | |
| Deferred Tax | $38M | $63M | $63M | $36M | $29M | $44M | $11M | $20M | $7M | $12M | $21M | $33M | |
| Other Non-current Liabilities | $59M | $68M | $75M | $75M | $80M | $100M | $89M | $29M | $34M | $22M | $26M | $32M | |
| Long-term Debt | $1.24B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $316M | $408M | $430M | |
| Total Debt | $1.22B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $315M | $408M | $428M | |
| Common Stock | $453.0K | $482.0K | $508.0K | $504.0K | $511.0K | $509.0K | $503.0K | $510.0K | $523.0K | $523.0K | $509.0K | $517.0K | |
| Retained Earnings | $279M | $352M | $360M | $253M | $202M | $158M | $79M | $161M | $267M | $290M | $316M | $420M | |
| AOCI | $-38M | $-55M | $-36M | $-30M | $-26M | $-30M | $-45M | $-30M | $-19M | $-33M | $-35M | $-22M | |
| Stockholders' Equity | $796M | $821M | $960M | $818M | $749M | $732M | $587M | $668M | $752M | $740M | $722M | $826M | |
| Liabilities + Equity | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Shares Outstanding | 45,252,667 | 48,215,899 | 50,787,859 | 50,448,519 | 51,124,240 | 50,868,820 | 50,322,930 | 51,019,918 | 52,342,965 | 52,255,495 | 50,932,348 | 51,670,969 |
Fluxo de Caixa 16
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $112M | $116M | $97M | $93M | $98M | $84M | $110M | $109M | $89M | $90M | $90M | $86M | |
| Stock-based Comp | $34M | $30M | $28M | $26M | $24M | $26M | $20M | $17M | $13M | $9M | $7M | $14M | |
| Deferred Tax | $-26M | $-6M | $-11M | $6M | $5M | $-21M | $-7M | $13M | $-6M | $-7M | $-1M | $4M | |
| Amort. of Intangibles | $50M | $56M | $41M | $42M | $57M | $41M | $34M | $25M | $32M | $37M | $59M | $34M | |
| Restructuring | $3M | $14M | $14M | $657.0K | $4M | $1M | $4M | $395.0K | $31M | $22M | $23M | $37M | |
| Operating Cash Flow | $293M | $182M | $182M | $273M | $172M | $109M | $158M | $159M | $220M | $160M | $122M | $127M | |
| CapEx | $33M | $39M | $38M | $191M | $97M | $37M | $49M | $119M | $75M | $76M | $102M | $122M | |
| Investing Cash Flow | $-180M | $-162M | $-322M | $-144M | $-86M | $-425M | $-57M | $-116M | $-63M | $-73M | $-105M | $-122M | |
| Debt Issued | · | · | · | · | · | · | $0 | $348M | $0 | $0 | · | $0 | |
| Net Debt Issued | · | $-5M | $-12M | $-10M | $-18M | $-22M | $-13M | $81M | $-62M | $-43M | $-21M | $-9M | |
| Stock Repurchased | $175M | $225M | $0 | $75M | $0 | $0 | $175M | $160M | $100M | $0 | $61M | $39M | |
| Net Stock Activity | $-175M | $-225M | $0 | $-75M | $0 | $0 | $-175M | $-160M | $-100M | $0 | $-61M | $-39M | |
| Financing Cash Flow | $-178M | $109M | $38M | $-100M | $-16M | $367M | $-131M | $-51M | $-121M | $-60M | $-63M | $-33M | |
| Net Change in Cash | $-61M | $128M | $-106M | $25M | $67M | $55M | $-32M | $-11M | $41M | $24M | $-46M | $-32M | |
| Taxes Paid | $61M | · | · | · | · | $12M | $12M | $8M | $9M | $7M | $8M | $11M | |
| Free Cash Flow | $260M | $142M | $115M | $163M | $76M | $72M | $109M | $40M | $146M | $84M | $19M | $5M |
Lucratividade 8
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% | 45.7% | 49.0% | 43.1% | 45.6% | 42.7% | 44.7% | 47.7% | |
| Operating Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| Net Margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% | 9.1% | 7.7% | 5.7% | 5.0% | -3.0% | -6.1% | 1.9% | |
| Pretax Margin | 9.6% | 15.6% | 11.6% | 12.1% | 6.4% | 8.4% | 8.8% | 7.6% | 6.6% | -3.1% | -5.9% | 3.4% | |
| EBITDA Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| ROA | 4.0% | 7.2% | 5.7% | 6.1% | 2.4% | 5.1% | 6.0% | 4.4% | 3.7% | -2.1% | -4.0% | 1.1% | |
| ROE | 11.8% | 19.4% | 12.3% | 14.5% | 5.9% | 11.0% | 13.2% | 8.7% | 6.1% | -3.6% | -7.2% | 2.0% | |
| ROIC | 5.9% | 8.6% | 7.2% | 8.0% | 3.6% | 6.8% | 9.4% | 6.1% | 4.3% | -1.8% | -4.0% | 1.8% |
Liquidez e Solvência 4
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 | 2.7 | 2.2 | 2.4 | 1.4 | 2.4 | 2.6 | 3.0 | |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 | 1.3 | 1.1 | 1.5 | 0.9 | 1.4 | 1.5 | 1.6 | |
| Debt / Equity | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 | 1.0 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.5 | |
| LT Debt / Equity | 1.5 | 1.1 | 0.8 | 0.9 | 0.7 | 0.9 | 0.5 | 0.5 | 0.1 | 0.3 | 0.5 | 0.5 |
Eficiência 3
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | |
| Inventory Turnover | 1.6 | 1.8 | 2.1 | 2.0 | 1.6 | 1.6 | 2.2 | 3.1 | 2.9 | 2.8 | 2.5 | 2.3 | |
| Receivables Turnover | 6.4 | 6.7 | 6.8 | 6.9 | 6.9 | 5.9 | 5.6 | 5.8 | 5.9 | 5.7 | 6.0 | 5.9 |
Taxas de Crescimento 9
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.0% | 4.0% | 12.0% | 17.7% | 14.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 11.1% | 14.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -38.1% | 44.5% | 2.2% | 166.7% | -45.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -2.9% | 58.0% | 13.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -42.0% | 42.6% | 1.9% | 166.1% | -45.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -5.5% | 56.9% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Net Income TTM | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| Market Cap | $2.45B | $3.05B | $4.33B | $4.17B | $3.26B | $5.70B | $5.08B | $4.46B | $3.83B | $2.12B | $1.80B | $2.28B | |
| Enterprise Value | $3.42B | $3.96B | $4.96B | $4.66B | $3.78B | $6.21B | $5.33B | $4.64B | $3.90B | $2.30B | $2.09B | $2.55B | |
| P/E | 26.4 | 19.1 | 37.3 | 36.9 | 76.0 | 72.3 | 68.2 | 84.1 | 86.1 | -79.5 | -32.4 | 138.2 | |
| P/S | 1.8 | 2.2 | 3.3 | 3.6 | 3.3 | 6.5 | 5.1 | 4.6 | 4.2 | 2.4 | 2.0 | 2.5 | |
| P/B | 3.1 | 3.7 | 4.5 | 5.1 | 4.4 | 7.8 | 8.7 | 6.7 | 5.1 | 2.9 | 2.5 | 2.8 | |
| P / Tangible Book | · | · | · | 54.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.3 | 16.8 | 23.8 | 15.3 | 18.9 | 52.4 | 32.1 | 28.0 | 17.4 | 13.3 | 14.7 | 18.0 | |
| P / FCF | 9.4 | 21.4 | 37.5 | 25.6 | 43.1 | 79.4 | 46.4 | 110.7 | 26.3 | 25.4 | 92.4 | 460.7 | |
| EV / EBITDA | 21.8 | 17.9 | 30.1 | 29.8 | 46.8 | 69.2 | 51.5 | 55.6 | 69.5 | -118.4 | -47.6 | 62.9 | |
| EV / FCF | 13.1 | 27.8 | 43.0 | 28.6 | 49.9 | 86.6 | 48.7 | 115.2 | 26.8 | 27.5 | 107.4 | 514.6 | |
| EV / Revenue | 2.6 | 2.9 | 3.8 | 4.0 | 3.8 | 7.1 | 5.4 | 4.8 | 4.3 | 2.6 | 2.3 | 2.8 | |
| Earnings Yield | 3.8% | 5.2% | 2.7% | 2.7% | 1.3% | 1.4% | 1.5% | 1.2% | 1.2% | -1.3% | -3.1% | 0.72% |
Demonstração de Resultados 16
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $339M | $346M | $339M | $327M | $321M | $331M | $349M | $346M | $336M | $343M | $336M | $318M | $340M | $305M | $297M | |
| Cost of Revenue | $137M | $148M | $137M | $133M | $129M | $138M | $155M | $158M | $161M | $167M | $158M | $148M | $169M | $147M | $140M | |
| Gross Profit | $203M | $198M | $202M | $195M | $192M | $193M | $194M | $187M | $175M | $176M | $178M | $171M | $172M | $159M | $158M | |
| R&D Expense | $16M | $14M | $14M | $15M | $16M | $18M | $16M | $14M | $14M | $16M | $13M | $13M | $16M | $13M | $11M | |
| SG&A Expense | $119M | $121M | $109M | $102M | $111M | $115M | $106M | $107M | $108M | $109M | $112M | $115M | $98M | $95M | $92M | |
| Operating Expenses | $145M | $221M | $135M | $136M | $138M | $122M | $135M | $136M | $135M | $146M | $132M | $135M | $121M | $115M | $111M | |
| Operating Income | $57M | $-23M | $67M | $58M | $54M | $71M | $59M | $52M | $40M | $30M | $46M | $35M | $51M | $43M | $47M | |
| Other Non-op | $-10M | $-5M | $-7M | $-7M | $-9M | $-598.0K | $-9M | $-7M | $7M | $-7M | $-2M | $-2M | $-3M | $-1M | $-6M | |
| Pretax Income | $48M | $-28M | $60M | $51M | $45M | $71M | $50M | $45M | $47M | $23M | $44M | $33M | $48M | $42M | $41M | |
| Income Tax | $15M | $-8M | $15M | $13M | $11M | $13M | $12M | $11M | $8M | $3M | $13M | $8M | $5M | $9M | $8M | |
| Net Income | $33M | $-20M | $45M | $39M | $34M | $58M | $37M | $34M | $38M | $20M | $31M | $25M | $42M | $33M | $33M | |
| EPS (Basic) | $0.73 | $-0.42 | $0.96 | $0.81 | $0.71 | $1.17 | $0.75 | $0.66 | $0.75 | $0.40 | $0.62 | $0.49 | $0.84 | $0.65 | $0.65 | |
| EPS (Diluted) | $0.72 | $-0.41 | $0.95 | $0.81 | $0.70 | $1.17 | $0.74 | $0.66 | $0.74 | $0.40 | $0.61 | $0.48 | $0.84 | $0.64 | $0.64 | |
| Shares (Basic) | 45,361,000 | -95,314,000 | 46,792,000 | 47,590,000 | 48,111,000 | -101,797,000 | 50,286,000 | 50,898,000 | 50,943,000 | 27,000 | 50,768,000 | 50,727,000 | -102,174,000 | 50,509,000 | 50,953,000 | |
| Shares (Diluted) | 45,704,000 | -95,650,000 | 46,987,000 | 47,664,000 | 48,353,000 | -102,713,000 | 50,639,000 | 51,240,000 | 51,564,000 | 3,000 | 51,445,000 | 51,396,000 | -103,165,000 | 51,219,000 | 51,558,000 | |
| EBITDA | $57M | · | $67M | $58M | $54M | · | $59M | $52M | $40M | · | $46M | $35M | · | $43M | $47M |
Balanço Patrimonial 25
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $223M | $245M | $363M | $296M | $293M | $307M | $321M | $299M | $344M | $179M | $194M | $351M | · | $224M | $241M | |
| Receivables | $216M | $217M | $196M | $207M | $201M | $203M | $212M | $214M | $201M | $207M | $212M | $174M | · | $181M | $172M | |
| Inventory | $307M | $306M | $321M | $336M | $361M | $365M | $360M | $382M | $374M | $317M | $304M | $286M | · | $256M | $255M | |
| Prepaid Expense | $65M | $66M | $63M | $60M | $59M | $60M | $113M | $61M | $59M | $66M | $55M | $55M | · | $45M | $48M | |
| Current Assets | $811M | $835M | $944M | $900M | $913M | $935M | $1.01B | $956M | $979M | $769M | $765M | $866M | · | $706M | $716M | |
| PP&E (Net) | $304M | $306M | $297M | $292M | $287M | $284M | $286M | $300M | $302M | $311M | $319M | $308M | · | $313M | $308M | |
| PP&E (Gross) | $854M | $842M | $837M | $815M | $795M | $837M | $867M | $939M | $949M | $959M | $979M | $950M | · | · | · | |
| Accum. Depreciation | $550M | $536M | $540M | $523M | $508M | $553M | $581M | $639M | $647M | $648M | $661M | $642M | · | · | · | |
| Goodwill | $657M | $656M | $607M | $606M | $607M | $604M | $605M | $616M | $613M | $565M | $555M | $465M | $466M | $466M | $465M | |
| Intangibles | $435M | $448M | $420M | $428M | $451M | $456M | $466M | $488M | $495M | $406M | $429M | $251M | · | $284M | $293M | |
| Other Non-current Assets | $150M | $142M | $216M | $208M | $196M | $164M | $160M | $156M | $142M | $136M | $127M | $117M | · | $103M | $80M | |
| Total Assets | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Accounts Payable | $56M | $51M | $49M | $62M | $46M | $67M | $63M | $69M | $77M | $73M | $57M | $80M | · | $64M | $61M | |
| Current Liabilities | $263M | $283M | $540M | $548M | $531M | $578M | $253M | $274M | $260M | $300M | $262M | $264M | · | $227M | $262M | |
| Capital Leases | · | $41M | · | · | · | $50M | · | · | · | $58M | · | · | · | · | · | |
| Deferred Tax | $39M | $38M | $56M | $58M | $59M | $63M | $61M | $63M | $65M | $63M | $62M | $35M | · | $40M | $36M | |
| Other Non-current Liabilities | $57M | $59M | $64M | $66M | $68M | $68M | $90M | $90M | $92M | $75M | $76M | $70M | · | $78M | $78M | |
| Long-term Debt | $1.19B | $1.24B | $1.22B | $1.22B | $1.22B | $1.25B | $1.22B | $1.22B | $1.22B | $808M | $871M | $762M | · | $767M | $818M | |
| Total Debt | $1.17B | · | $1.22B | $1.22B | $1.22B | · | $1.22B | $1.22B | $1.22B | · | $871M | $762M | · | $767M | $818M | |
| Common Stock | $455.0K | $453.0K | $468.0K | $467.0K | $482.0K | $482.0K | $502.0K | $504.0K | $512.0K | $508.0K | $508.0K | $507.0K | · | $504.0K | $506.0K | |
| Retained Earnings | $312M | $279M | $381M | $336M | $356M | $352M | $392M | $369M | $387M | $360M | $340M | $309M | · | $224M | $204M | |
| AOCI | $-42M | $-38M | $-35M | $-41M | $-36M | $-55M | $-56M | $-35M | $-43M | $-36M | $-24M | $-33M | · | $-36M | $-40M | |
| Stockholders' Equity | $837M | $796M | $911M | $849M | $882M | $821M | $907M | $879M | $905M | $960M | $943M | $894M | $818M | $776M | $729M | |
| Liabilities + Equity | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Shares Outstanding | 45,471,313 | 45,252,667 | 46,829,249 | 46,747,381 | 48,158,723 | 48,215,899 | 50,235,051 | 50,381,127 | 51,152,886 | 50,787,859 | 50,785,040 | 50,740,389 | · | 50,444,470 | 50,605,499 |
Fluxo de Caixa 13
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $27M | $27M | $28M | $29M | $28M | $29M | $29M | $29M | $28M | $24M | · | $24M | $24M | · | |
| Stock-based Comp | $9M | $9M | $8M | $8M | $9M | $7M | $8M | $7M | $8M | $7M | $7M | · | $7M | $7M | · | |
| Deferred Tax | $668.0K | $-20M | $-2M | $-725.0K | $-3M | $3M | $-2M | $-2M | $-4M | $-6M | $-3M | · | · | · | · | |
| Amort. of Intangibles | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $13M | $9M | $9M | $15M | $10M | $11M | |
| Restructuring | $2M | $196.0K | $1M | $204.0K | $1M | $984.0K | $4M | $5M | $5M | $6M | $8M | $86.0K | $701.0K | $44.0K | $165.0K | |
| Operating Cash Flow | $52M | $71M | $94M | $111M | $17M | $117M | $44M | $49M | $-27M | $64M | $-540.0K | · | $80M | $64M | · | |
| CapEx | $8M | $18M | $6M | $5M | $4M | $16M | $9M | $9M | $6M | $7M | $-3M | · | $93M | $17M | · | |
| Investing Cash Flow | $-22M | $-87M | $-29M | $-30M | $-33M | $18M | $-17M | $-23M | $-139M | $-13M | $-269M | · | $-18M | $-36M | · | |
| Net Debt Issued | $-2M | · | · | · | $-2M | · | · | · | $-2M | · | · | · | · | · | · | |
| Stock Repurchased | · | $100M | $0 | · | · | $150M | $0 | · | · | $0 | $0 | · | $0 | $0 | · | |
| Financing Cash Flow | $-52M | $-101M | $2M | $-77M | $-2M | $-151M | $1M | $-75M | $334M | $-64M | $109M | · | $-2M | $-50M | · | |
| Net Change in Cash | $-22M | $-118M | $67M | $4M | $-14M | $-14M | $22M | $-45M | $166M | $-15M | $-157M | · | $60M | $-17M | · | |
| Free Cash Flow | $44M | · | · | · | $14M | · | · | · | $-33M | · | · | · | · | · | · |
Lucratividade 8
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | · | 59.7% | 59.5% | 59.8% | · | 55.5% | 54.2% | 52.0% | · | 52.9% | 53.6% | · | 52.0% | 53.1% | |
| Operating Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| Net Margin | 9.7% | · | 13.2% | 11.8% | 10.6% | · | 10.8% | 9.8% | 11.4% | · | 9.3% | 7.8% | · | 10.8% | 11.2% | |
| Pretax Margin | 14.0% | · | 17.7% | 15.7% | 14.1% | · | 14.3% | 12.9% | 13.9% | · | 13.1% | 10.3% | · | 13.8% | 13.8% | |
| EBITDA Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| ROA | 1.4% | · | 1.8% | 1.6% | 1.4% | · | 1.6% | 1.5% | 1.7% | · | 1.5% | 1.3% | · | 1.8% | 1.8% | |
| ROE | 3.8% | · | 4.9% | 4.5% | 3.8% | · | 4.0% | 3.8% | 4.3% | · | 3.6% | 3.1% | · | 4.4% | 4.7% | |
| ROIC | 2.0% | · | 2.4% | 2.1% | 1.9% | · | 2.1% | 1.9% | 1.5% | · | 1.8% | 1.6% | · | 2.2% | 2.4% |
Liquidez e Solvência 4
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | 1.7 | 1.6 | 1.7 | · | 4.0 | 3.5 | 3.8 | · | 2.9 | 3.3 | · | 3.1 | 2.7 | |
| Quick Ratio | 1.7 | · | 1.0 | 0.9 | 0.9 | · | 2.1 | 1.9 | 2.1 | · | 1.5 | 2.0 | · | 1.8 | 1.6 | |
| Debt / Equity | 1.4 | · | 1.3 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 0.9 | 0.9 | · | 1.0 | 1.1 | |
| LT Debt / Equity | 1.4 | · | 1.0 | 1.1 | 1.0 | · | 1.3 | 1.4 | 1.3 | · | 0.9 | 0.8 | · | 1.0 | 1.0 |
Eficiência 3
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| Receivables Turnover | 1.6 | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.8 | 1.8 | · | 1.7 | 1.8 | · | 1.8 | 1.9 |
Avaliação (TTM) 14
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | · | $1.34B | $1.34B | $1.35B | · | $1.37B | $1.34B | $1.30B | · | $1.27B | $1.23B | · | · | · | |
| Net Income TTM | $150M | · | $155M | $144M | $144M | · | $141M | $128M | $136M | · | $130M | $132M | · | · | · | |
| Market Cap | $3.51B | · | $3.76B | $2.25B | $3.55B | · | $3.90B | $4.02B | $4.23B | · | $4.34B | $4.55B | · | $3.97B | $3.75B | |
| Enterprise Value | $4.47B | · | $4.62B | $3.18B | $4.49B | · | $4.80B | $4.95B | $5.11B | · | $5.02B | $4.96B | · | $4.51B | $4.32B | |
| P/E | 24.3 | · | 25.1 | 16.6 | 26.0 | · | 28.2 | 32.0 | 31.5 | · | 33.8 | 35.0 | · | · | · | |
| P/S | 2.6 | · | 2.8 | 1.7 | 2.6 | · | 2.9 | 3.0 | 3.3 | · | 3.4 | 3.7 | · | · | · | |
| P/B | 4.2 | · | 4.1 | 2.7 | 4.0 | · | 4.3 | 4.6 | 4.7 | · | 4.6 | 5.1 | · | 5.1 | 5.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 25.6 | · | 155.7 | · | |
| P / Cash Flow | 67.2 | · | · | · | 204.3 | · | · | · | -154.3 | · | · | · | · | · | · | |
| P / FCF | 79.1 | · | · | · | 260.5 | · | · | · | -127.9 | · | · | · | · | · | · | |
| EV / EBITDA | 77.7 | · | 68.6 | 54.4 | 83.3 | · | 81.3 | 95.7 | 128.6 | · | 109.2 | 140.4 | · | 104.2 | 92.5 | |
| EV / FCF | 100.5 | · | · | · | 328.9 | · | · | · | -154.5 | · | · | · | · | · | · | |
| EV / Revenue | 3.4 | · | 3.5 | 2.4 | 3.3 | · | 3.5 | 3.7 | 3.9 | · | 3.9 | 4.0 | · | · | · | |
| Earnings Yield | 4.1% | · | 4.0% | 6.0% | 3.9% | · | 3.5% | 3.1% | 3.2% | · | 3.0% | 2.9% | · | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Receita | $1.33B | $1.36B | $1.31B | $1.17B | $993M |
| Margem Bruta % | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| Margem Operacional % | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% |
| Lucro líquido | $97M | $168M | $118M | $115M | $43M |
| EPS Diluído | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
Balanço Patrimonial
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 |
| Índice de liquidez corrente | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 |
| Índice de Liquidez Seca | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 |
Fluxo de Caixa
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $260M | $142M | $115M | $163M | $76M |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 363 declarantes · $2.6B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 56 (-3 vs trimestre anterior) | 43 (-12 vs trimestre anterior) | 111 (-2 vs trimestre anterior) | 114 (-1 vs trimestre anterior) | +1.2M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $349.945.961 | 4.366.138 | 13,44% | Ações |
| NEUBERGER BERMAN GROUP LLC | $308.172.249 | 4.108.761 | 11,84% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $190.979.550 | 2.546.394 | 7,34% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $154.468.350 | 2.059.578 | 5,93% | Ações |
| STATE STREET CORP | $136.363.950 | 1.818.186 | 5,24% | Ações |
| CITADEL ADVISORS LLC | $113.259.000 | 1.510.120 | 4,35% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $109.143.975 | 1.455.253 | 4,19% | Ações |
| River Road Asset Management, LLC | $96.420.150 | 1.285.602 | 3,70% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $86.651.325 | 1.155.351 | 3,33% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $79.315.930 | 1.057.321 | 3,05% | Ações |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $62.319.375 | 830.925 | 2,39% | Ações |
| GOLDMAN SACHS GROUP INC | $52.644.150 | 701.922 | 2,02% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $44.356.725 | 591.423 | 1,70% | Ações |
| MILLENNIUM MANAGEMENT LLC | $42.780.975 | 570.413 | 1,64% | Ações |
| Holocene Advisors, LP | $41.264.625 | 550.195 | 1,58% | Ações |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $37.034.909 | 493.796 | 1,42% | Ações |
| North Peak Capital Management, LLC | $25.730.775 | 343.077 | 0,99% | Ações |
| LONDON CO OF VIRGINIA | $25.543.299 | 340.574 | 0,98% | Ações |
| DEUTSCHE BANK AG\ | $25.282.575 | 337.101 | 0,97% | Ações |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $24.905.625 | 332.075 | 0,96% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $24.779.850 | 330.398 | 0,95% | Ações |
| Boston Trust Walden Corp | $24.170.475 | 322.273 | 0,93% | Ações |
| Aristotle Capital Boston, LLC | $21.721.809 | 289.624 | 0,83% | Ações |
| MIZUHO MARKETS AMERICAS LLC | $21.166.050 | 282.214 | 0,81% | Ações |
| BANK OF AMERICA CORP /DE/ | $20.122.875 | 268.305 | 0,77% | Ações |
| Invenomic Capital Management LP | $16.216.275 | 216.217 | 0,62% | Ações |
| FMR LLC | $15.638.325 | 208.511 | 0,60% | Ações |
| HEARTLAND ADVISORS INC | $15.000.000 | 200.000 | 0,58% | Ações |
| GLENMEDE TRUST CO NA | $14.454.000 | 192.720 | 0,56% | Ações |
| MORGAN STANLEY | $13.073.475 | 174.313 | 0,50% | Ações |
| Longaeva Partners L.P. | $12.286.650 | 163.822 | 0,47% | Ações |
| RHUMBLINE ADVISERS | $10.812.225 | 144.163 | 0,42% | Ações |
| AMERICAN CENTURY COMPANIES INC | $10.613.250 | 141.510 | 0,41% | Ações |
| Balyasny Asset Management L.P. | $10.123.575 | 134.981 | 0,39% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $9.750.000 | 130.000 | 0,37% | Ações |
| Point72 Asset Management, L.P. | $8.192.700 | 109.236 | 0,31% | Ações |
| Verition Fund Management LLC | $7.913.100 | 105.508 | 0,30% | Ações |
| ARIEL INVESTMENTS, LLC | $7.569.975 | 100.933 | 0,29% | Ações |
| MILLENNIUM MANAGEMENT LLC | $7.500.000 | 100.000 | 0,29% | Opção de compra |
| KESTREL INVESTMENT MANAGEMENT CORP | $7.305.000 | 97.400 | 0,28% | Ações |
| Divisadero Street Capital Management, LP | $7.234.425 | 96.459 | 0,28% | Ações |
| Swiss National Bank | $6.997.500 | 93.300 | 0,27% | Ações |
| GOLDMAN SACHS GROUP INC | $6.750.000 | 90.000 | 0,26% | Opção de compra |
| GOLDMAN SACHS GROUP INC | $6.750.000 | 90.000 | 0,26% | Opção de venda |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.510.000 | 86.800 | 0,25% | Opção de compra |
| Squarepoint Ops LLC | $6.459.300 | 86.124 | 0,25% | Ações |
| RAYMOND JAMES FINANCIAL INC | $6.215.025 | 82.867 | 0,24% | Ações |
| Quantinno Capital Management LP | $5.477.550 | 73.034 | 0,21% | Ações |
| ROYCE & ASSOCIATES LP | $5.360.625 | 71.475 | 0,21% | Ações |
| AMERIPRISE FINANCIAL INC | $5.358.525 | 71.447 | 0,21% | Ações |
| JUPITER ASSET MANAGEMENT LTD | $5.229.300 | 69.724 | 0,20% | Ações |
| ALLIANCEBERNSTEIN L.P. | $5.166.634 | 91.672 | 0,20% | Ações |
| SEGALL BRYANT & HAMILL, LLC | $5.106.900 | 68.092 | 0,20% | Ações |
| AMERICAN CAPITAL MANAGEMENT INC | $5.018.625 | 66.915 | 0,19% | Ações |
| ISTHMUS PARTNERS, LLC | $4.946.325 | 65.951 | 0,19% | Ações |
| Corient Private Wealth LP | $4.851.975 | 64.693 | 0,19% | Ações |
| FIRST TRUST ADVISORS LP | $4.751.850 | 63.358 | 0,18% | Ações |
| DEAN INVESTMENT ASSOCIATES, LLC | $4.649.175 | 61.989 | 0,18% | Ações |
| PEREGRINE CAPITAL MANAGEMENT LLC | $4.497.450 | 59.966 | 0,17% | Ações |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4.484.325 | 59.791 | 0,17% | Ações |
| Bridgewater Associates, LP | $4.479.975 | 59.733 | 0,17% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $4.181.475 | 55.753 | 0,16% | Ações |
| Trexquant Investment LP | $3.946.425 | 52.619 | 0,15% | Ações |
| Aequim Alternative Investments LP | $3.840.000 | 51.200 | 0,15% | Ações |
| RICE HALL JAMES & ASSOCIATES, LLC | $3.827.850 | 51.038 | 0,15% | Ações |
| JANE STREET GROUP, LLC | $3.682.500 | 49.100 | 0,14% | Opção de compra |
| MetLife Investment Management, LLC | $3.681.075 | 49.081 | 0,14% | Ações |
| BlackRock, Inc. | $3.618.975 | 48.253 | 0,14% | Ações |
| Retirement Systems of Alabama | $3.604.875 | 48.065 | 0,14% | Ações |
| Riverwater Partners LLC | $3.573.375 | 47.645 | 0,14% | Ações |
| Skylands Capital, LLC | $3.571.875 | 47.625 | 0,14% | Ações |
| FIFTH THIRD BANCORP | $3.561.472 | 47.486 | 0,14% | Ações |
| ALGERT GLOBAL LLC | $3.522.750 | 46.970 | 0,14% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.441.750 | 45.890 | 0,13% | Ações |
| Qube Research & Technologies Ltd | $3.425.475 | 45.673 | 0,13% | Ações |
| Dean Capital Management | $3.372.600 | 44.968 | 0,13% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.351.375 | 44.685 | 0,13% | Ações |
| EASTERLY INVESTMENT PARTNERS LLC | $3.248.025 | 43.307 | 0,12% | Ações |
| Phocas Financial Corp. | $3.227.250 | 43.030 | 0,12% | Ações |
| ZB,N.A. | $3.200.968 | 40.996 | 0,12% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3.190.200 | 42.536 | 0,12% | Ações |
| CONNORS INVESTOR SERVICES INC | $3.150.000 | 42.000 | 0,12% | Ações |
| Expect Equity LLC | $3.076.950 | 41.026 | 0,12% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.964.874 | 52.606 | 0,11% | Ações |
| BEACON INVESTMENT ADVISORS LLC | $2.783.648 | 37.115 | 0,11% | Ações |
| Campbell & CO Investment Adviser LLC | $2.763.300 | 36.844 | 0,11% | Ações |
| Assenagon Asset Management S.A. | $2.633.175 | 35.109 | 0,10% | Ações |
| BARCLAYS PLC | $2.448.300 | 32.644 | 0,09% | Ações |
| MARSHALL WACE, LLP | $2.286.975 | 30.493 | 0,09% | Ações |
| Cubist Systematic Strategies, LLC | $2.219.702 | 45.541 | 0,09% | Ações |
| XTX Topco Ltd | $2.208.150 | 29.442 | 0,08% | Ações |
| Legal & General Group Plc | $2.032.875 | 27.105 | 0,08% | Ações |
| CARY STREET PARTNERS FINANCIAL LLC | $1.999.800 | 26.664 | 0,08% | Ações |
| Nierenberg Investment Management Company, LLC | $1.971.000 | 26.280 | 0,08% | Ações |
| Aurora Investment Counsel | $1.912.575 | 25.501 | 0,07% | Ações |
| WESBANCO BANK INC | $1.912.500 | 25.500 | 0,07% | Ações |
| Cardinal Capital Management | $1.861.275 | 24.817 | 0,07% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $1.846.275 | 24.617 | 0,07% | Ações |
| Legato Capital Management LLC | $1.758.750 | 23.450 | 0,07% | Ações |
| CITADEL ADVISORS LLC | $1.740.000 | 23.200 | 0,07% | Opção de compra |
Executivos da empresa 72 insiders · 48 diretores · 25 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Christopher Simon, | President & CEO | 15 de Maio de 2026 A | 444.704 | 0 | 0 | $0 |
| Brian Concannon | President & CEO | 15 de Setembro de 2015 M | 147.040 | 0 | 0 | $0 |
| James Darecca | EVP, Chief Financial Officer | 15 de Maio de 2026 A | 54.444 | 0 | 0 | $0 |
| William P. Mr. Burke | EVP, Chief Financial Officer | 23 de Agosto de 2021 M | 30.291 | 0 | 0 | $0 |
| Christopher J Lindop | CFO & EVP Business Development | 13 de Janeiro de 2016 A | 56.743 | 0 | 0 | $0 |
| Ronald J Ryan | VP and CFO | 1 de Novembro de 2006 P | 2.101 | 0 | 0 | $0 |
| Stewart W Strong | President, Global Hospital | 26 de Julho de 2024 S | 18.196 | 0 | 0 | $0 |
| Byron Selman | President, Global Markets | 25 de Outubro de 2016 A | 23.318 | 0 | 0 | $0 |
| Peter M Allen | President, Global Plasma | 6 de Julho de 2015 M | 34.102 | 0 | 0 | $0 |
| Kelly Michael P | President, Global Markets | 11 de Novembro de 2013 M | 10.987 | 0 | 0 | $0 |
| Mikael Gordon | President, Global Markets | 3 de Maio de 2012 M | 4.442 | 0 | 0 | $0 |
| Remi Corlin | President, Asia | 8 de Agosto de 2008 M | 884 | 0 | 0 | $0 |
| Keiko Hattori | President, Haemonetics Japan | 1 de Maio de 2008 P | 716 | 0 | 0 | $0 |
| Thomas Lawlor | President, Patient Division | 28 de Novembro de 2007 M | 0 | 0 | 0 | $0 |
| Ryoji Sakai | President, Japan | 14 de Junho de 2007 M | 0 | 0 | 0 | $0 |
| Ulrich Eckert | President, Europe & Latin Am | 1 de Novembro de 2006 P | 890 | 0 | 0 | $0 |
| Yutaka Sakurada | President, Japan & Asia | 2 de Maio de 2005 P | 2.347 | 0 | 0 | $0 |
| Frank Chan | EVP, Chief Operating Officer | 15 de Maio de 2026 A | 32.936 | 0 | 0 | $0 |
| Kent J Davies | Chief Operating Officer | 23 de Outubro de 2015 S | 16.891 | 0 | 0 | $0 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 5 de Junho de 2026 F | 6.242 | 0 | 0 | $0 |
| Laurie A. Miller | SVP, Human Resources | 5 de Junho de 2026 F | 40.987 | 0 | 0 | $0 |
| Roy Galvin | EVP, Chief Commercial Officer | 15 de Maio de 2026 A | 39.882 | 0 | 0 | $0 |
| Michelle L Basil | EVP and General Counsel | 15 de Maio de 2026 A | 68.829 | 0 | 0 | $0 |
| Anila Lingamneni | EVP, Chief Technology Officer | 12 de Julho de 2024 S | 21.331 | 0 | 0 | $0 |
| Josep Llorens | EVP, Global Manufacturing | 28 de Maio de 2024 F | 30.940 | 0 | 0 | $0 |
| Dan Goldstein | VP, Corporate Controller | 13 de Junho de 2022 S | 4.447 | 0 | 0 | $0 |
| Jacqueline Scanlan | SVP, Global Human Resources | 7 de Junho de 2021 S | 4.216 | 0 | 0 | $0 |
| Said Bolorforosh | EVP, Chief Technology Officer | 11 de Novembro de 2019 S | 1.977 | 0 | 0 | $0 |
| Neil 122-62-507 Ryding | EVP, Global Manufacturing | 7 de Junho de 2018 S | 15.226 | 0 | 0 | $0 |
| David Fusco | EVP, Global Human Resources | 25 de Outubro de 2016 A | 16.867 | 0 | 0 | $0 |
| Sandra Jesse | EVP and Chief Legal Officer | 25 de Outubro de 2016 A | 48.166 | 0 | 0 | $0 |
| Jonathan White | Chief Science and Technology | 26 de Outubro de 2015 S | 30.507 | 0 | 0 | $0 |
| Susan M Hanlon | VP Finance | 26 de Outubro de 2015 S | 20.464 | 0 | 0 | $0 |
| Brian R Burns | EVP, Global QA/RA | 23 de Outubro de 2015 S | 16.235 | 0 | 0 | $0 |
| Dave Helsel | EVP, Global Manufacturing | 13 de Abril de 2015 D | 13.216 | 0 | 0 | $0 |
| Kathleen Mcdaniel | EVP Global Human Resources | 28 de Agosto de 2014 S | 5.013 | 0 | 0 | $0 |
| Warren Nighan JR | EVP, Global QA/RA | 24 de Julho de 2013 A | 7.618 | 0 | 0 | $0 |
| Joseph J Forish | VP, Human Resources | 30 de Abril de 2013 P | 17.279 | 0 | 0 | $0 |
| Phillip John Brancazio | VP, Global Manufacturing | 4 de Maio de 2011 P | 3.052 | 0 | 0 | $0 |
| Alicia R Lopez | VP, Corporate Affairs | 5 de Abril de 2011 D | 2.815 | 0 | 0 | $0 |
| Michael I Ruxin | VP Global Software Strategies | 4 de Novembro de 2010 P | 215 | 0 | 0 | $0 |
| Brad Nutter | Chairman of the Board | 29 de Julho de 2010 A | 10.580 | 0 | 0 | $0 |
| Robert B Ebbeling | Vice President, Operations | 1 de Maio de 2009 P | 15.849 | 0 | 0 | $0 |
| Jan Conneely | VP & GM, Arryx, Inc. | 1 de Maio de 2008 P | 1.041 | 0 | 0 | $0 |
| William Granville | VP, Manufacturing | 1 de Maio de 2008 P | 12.188 | 0 | 0 | $0 |
| Mark A Popovsky | VP, Corporate Medical Director | 1 de Maio de 2008 P | 4.891 | 0 | 0 | $0 |
| Stephen Swenson | VP & General Mgr, Global Plasm | 1 de Maio de 2008 P | 3.024 | 0 | 0 | $0 |
| William Roche Still | VP & Gen Mrg, Therapeutics Bus | 4 de Maio de 2007 M | 4.193 | 0 | 0 | $0 |
| Lloyd Emerson Johnson | Conselheiro | 24 de Julho de 2026 A | 15.471 | 0 | 0 | $0 |
| Diane M Bryant | Conselheiro | 24 de Julho de 2026 A | 9.664 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 8 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 6 de Fevereiro de 2004 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 20 de Agosto de 2003 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 8 de Agosto de 2003 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 24 de Junho de 2003 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 19 de Junho de 2003 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 3 de Junho de 2003 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 27 de Maio de 2003 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 15 de Junho de 2001 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 88 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| NBSM · Neuberger Berman ETF Trust | 1,86% | 61.981 NS | 31 de Maio de 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,84% | 43.927 NS | 30 de Abril de 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,77% | 125.093 NS | 30 de Abril de 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,64% | 5.836 NS | 30 de Abril de 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,46% | 12.701 NS | 31 de Maio de 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,36% | 110.180 NS | 30 de Junho de 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,35% | 201.070 NS | 30 de Abril de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,32% | 35.814 NS | 31 de Maio de 2026 | N-PORT |
| ABCS · EA Series Trust | 0,31% | 522 NS | 29 de Maio de 2026 | N-PORT |
| IWO · iShares Trust | 0,30% | 412.951 SH | 21 de Agosto de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,29% | 75.696 SH | 21 de Agosto de 2026 | Diário |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,24% | 41.437 NS | 30 de Abril de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,20% | 47.624 SH | 19 de Agosto de 2026 | Diário |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,19% | 76.694 NS | 31 de Maio de 2026 | N-PORT |
| IWM · iShares Trust | 0,16% | 1.207.897 SH | 21 de Agosto de 2026 | Diário |
| PKW · Invesco Exchange-Traded Fund Trust | 0,15% | 24.453 SH | 21 de Agosto de 2026 | Diário |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 17.393 NS | 30 de Abril de 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,13% | 5.332 SH | 21 de Agosto de 2026 | Diário |
| MIDE · DBX ETF Trust | 0,13% | 63 NS | 29 de Maio de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,13% | 1.703 NS | 30 de Abril de 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 12.097 NS | 30 de Abril de 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,12% | 2.419 NS | 30 de Abril de 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,11% | 27.512 SH | 19 de Agosto de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 271.486 SH | 19 de Agosto de 2026 | Diário |
| ESML · iShares Trust | 0,11% | 29.457 SH | 21 de Agosto de 2026 | Diário |
| NUSC · Nushares ETF Trust | 0,11% | 23.551 NS | 30 de Abril de 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 42.163 NS | 30 de Abril de 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,10% | 74.976 SH | 19 de Agosto de 2026 | Diário |
| FNDA · SCHWAB STRATEGIC TRUST | 0,10% | 126.817 NS | 31 de Maio de 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 6.131 SH | 21 de Agosto de 2026 | Diário |
| EBIT · Harbor ETF Trust | 0,09% | 168 NS | 30 de Abril de 2026 | N-PORT |
| RSSL · Global X Funds | 0,09% | 20.324 NS | 30 de Abril de 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,08% | 15.968 SH | 19 de Agosto de 2026 | Diário |
| ITWO · ProShares Trust | 0,08% | 2.210 NS | 31 de Maio de 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,08% | 5.212 NS | 30 de Abril de 2026 | N-PORT |
| ISCB · iShares Trust | 0,08% | 2.011 SH | 21 de Agosto de 2026 | Diário |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,07% | 9.144 SH | 21 de Agosto de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,07% | 159.737 NS | 30 de Abril de 2026 | N-PORT |
| MVV · ProShares Trust | 0,07% | 1.606 NS | 31 de Maio de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,07% | 222.776 NS | 31 de Maio de 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 12.283 NS | 30 de Abril de 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 5.390 SH | 21 de Agosto de 2026 | Diário |
| MIDU · Direxion Shares ETF Trust | 0,06% | 770 NS | 30 de Abril de 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,05% | 2.220 NS | 31 de Maio de 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,05% | 1.979 NS | 31 de Maio de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 302.003 SH | 19 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,05% | 139.826 SH | 19 de Agosto de 2026 | Diário |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,05% | 3.866 NS | 30 de Abril de 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 3.008 SH | 21 de Agosto de 2026 | Diário |
| UMDD · ProShares Trust | 0,05% | 224 NS | 31 de Maio de 2026 | N-PORT |